Anti- Mycobacterium tuberculosis Activities of New Fluoroquinolones in Combination with Other Antituberculous Drugs
- 30 April 2002
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 44 (3) , 160-165
- https://doi.org/10.1053/jinf.2002.0973
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 25 references indexed in Scilit:
- Relative Importance of NF-κB p50 in Mycobacterial InfectionInfection and Immunity, 2001
- The Clinical Use of Fluoroquinolones for the Treatment of Mycobacterial DiseasesClinical Infectious Diseases, 1997
- Tuberculosis into the next century: Proceedings of a symposium held on 4 February 1995 at the Liverpool School of Tropical MedicineJournal of Medical Microbiology, 1996
- In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1995
- Intracellular activities of roxithromycin used alone and in association with other drugs against Mycobacterium avium complex in human macrophagesAntimicrobial Agents and Chemotherapy, 1995
- Activity of levofloxacin in a murine model of tuberculosisAntimicrobial Agents and Chemotherapy, 1994
- Treatment and prevention of multidrug-resistant tuberculosisResearch in Microbiology, 1993
- Mycobacterium avium Infection and AIDS: A Therapeutic Dilemma in Rapid EvolutionThe Journal of Infectious Diseases, 1991
- Mycobacteria and the new quinolonesAntimicrobial Agents and Chemotherapy, 1989
- The fluoroquinolones: pharmacology, clinical uses, and toxicities in humansAntimicrobial Agents and Chemotherapy, 1985